|
 |
TriazThis page contains recent news articles, when available, and an overview of Triaz but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.It credited the gains to greater sales of Solodyn and Ziana, and the launch of Triaz foaming cloths in April. Non-acne revenue fell to $37.1 million from Washington Examiner BUYINS.NET: KTC, GG, PCBC, MRX, AET, CACI Are Seasonally Biased To ... - Jul 2, 2009 ...a cleanser product; SOLODYN for the treatment of inflammatory lesions; TRIAZ, a benzoyl peroxide pad for the topical treatment of acne vulgaris; TMC Net Medicis Announces New Notice of Allowance for SOLODYN(R) 90mg - Apr 17, 2009 PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), GlobeNewsWire (press release) Open korfbaltraining Triaz - Apr 17, 2009 INGEZONDEN Korfbalvereniging Triaz in Buitenveldert houdt op vrijdag 15 mei een open trainingsavond voor kinderen uit Amsterdam en omgeving. De Echo Verlies voor korfballers bij herstart veldcompetitie - Apr 6, 2009 In Amsterdam verloren de korfballers met 19-12 van Triaz. Door de nederlaag blijven de Almeerders zonder ook maar één zege in de eerste klasse. Almere Vandaag BUYINS.NET: Market Maker Surveillance Report. Top 6 Abnormal Price ... - 18 Mar 2009 ...a cleanser product; SOLODYN for the treatment of inflammatory lesions; TRIAZ, a benzoyl peroxide pad for the topical treatment of acne vulgaris; Trading Markets (press release) Medicis reports 4Q loss on charges - Feb 25, 2009 During the fourth quarter, sales of acne treatments, which include Solodyn, Triaz and Ziana, rose 19 percent to $92.2 million, while non-acne products sales Forbes Medicis Announces 2008 Fourth Quarter and Year-End Conference Call ... - Feb 23, 2009 PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), MSNBC ZKC tegen ZKV om lijfsbehoud - Mar 11, 2009 ...(Foto: Ronald Goedheer) ZAANDAM - De onverwachte zege tegen Triaz afgelopen weekend bestempelt ZKC'31-voorzitter Gosse Plantinga als óntzettend belangrijk De Zaankanter High Tea & Toothpaste op derde IGLO spelmiddag - Mar 13, 2009 De spelmiddag vindt plaats op zondag 22 maart van 14:00-17:00 uur in het clubhuis van korfbalvereniging Triaz, Van Heenvlietlaan 6, Buitenveldert. De Echo AcelRx Pharmaceuticals Reports Positive Results from a Clinical ... - Jan 13, 2009 AcelRx Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on the treatment of intermittent and acute medical conditions with an PR-USA.net (press release), Atlantis 2 verliest van EKVA 4 - Feb 2, 2009 Hopelijk gaat Atlantis volgende week de 2 punten pakken die ze heel hard nodig hebben. Er wordt dan gespeeld tegen Triaz om 16.15 in Amsterdam. regiosportaktueel.nl, Medicis to Present At RBC Capital Markets Healthcare Conference - Dec 8, 2008 PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), MarketWatch Medicis and IMPAX Announce R&D Collaboration and Settlement - Dec 1, 2008 PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), MarketWatch BUYINS.NET: Market Maker Surveillance Report. Top 6 Winning Stocks ... - Dec 2, 2008 SOLODYN, an antibiotic for the treatment of red, pus-filled pimples; TRIAZ, benzoyl peroxide pads for the topical treatment of acne vulgaris; and ZIANA, Trading Markets (press release), Velocitas blijkt opnieuw breekbaar - Dec 22, 2008 Na de kerstpauze zal er tegen Triaz aangetreden moeten worden, de huidige nummer 7, het tweede staat zelf op plaats 6. Unity FM, Korfbal - Atlantis 2 weet derde maal op rij te winnen | 09-12-2008 - Dec 8, 2008 Het gesponsorde Fortis team van Atlantis speelde een thuiswedstrijd tegen Triaz 3 uit Amsterdam. Het Atlantis team begon met de volgende opstelling: in de regiosportaktueel.nl, Nipte overwinning voor Atlantis 2 - Dec 1, 2008 Volgende weekend wordt er om 16:30 uur in Mijdrecht gespeeld tegen Triaz. We hopen u dan allen weer te zien om ons aan te moedigen. 0297-online.nl, Medicis Pharmaceutical Corporation - Premium Company Profile - New ... - Nov 14, 2008 In the dermatological field it offers products such as Dynacin, Plexion, Solodyn, Triaz and Ziana for the treatment of acne and acne-related dermatological Live-PR.com (Pressemitteilung), Medicis Reports Third Quarter 2008 Financial Results - Nov 10, 2008 Medicis' acne products include primarily PLEXION(R), SOLODYN(R), TRIAZ(R) and ZIANA(R). Medicis recorded net revenues of approximately $34.1 million MarketWatch Medicis Announces Third Quarter 2008 Conference Call and Webcast - Nov 6, 2008 PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), MarketWatch District Court Affirms Dismissal of Prasco's Declaratory Judgment ... - Oct 7, 2008 Medicis markets a benzoyl peroxide cleansing product, Triaz. Prasco sells a competing benzoyl peroxide cleansing product, Oscion. Prasco filed a declaratory Seeking Alpha, [Appealed from SD Ohio, Judge Barrett] - Sep 29, 2008 Prasco makes a generic benzoyl peroxide cleaning product OSCION", which it alleged would directly compete with Medicis's TRIAZ® product. Mondaq News Alerts (subscription), Medicis Announces FDA Approval of PMA Supplement for RESTYLANE - Oct 10, 2008 PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), Trading Markets (press release), Futura steviger in de subtop - Oct 19, 2008 Refleks doet het goed in 1E, waar het na een 11-7 zege op Triaz momenteel de tweede plaats op de ranglijst inneemt. Ondanks de belangrijke punten was coach Algemeen Dagblad, Afgelasting komt EKVA goed uit - Oct 6, 2008 Door de overvloedige regen van dit weekend stond het kunstgrasveld van de Amsterdamse korfbalvereniging Triaz zondag volledig onder water. Almere Vandaag, Marking of Prescription Drug Does Not Create DJ Jurisdiction for ... - Aug 19, 2008 Medicis is the exclusive licensee and sells the product under the brand name TRIAZ. The patents are listed on the box. Prasco makes a generic version Patently-O, Silence Golden For Medicis Pharma in Avoiding Judgment - Sep 11, 2008 Medicis markets a benzoyl peroxide cleansing product TRIAZ®, which is marked as being covered by US Patent Nos. 5648389; 5254334; 5409706; and 5632996. Patent Baristas, Medicis to Present At Thomas Weisel Partners Healthcare Conference ... - Sep 2, 2008 PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), GlobeNewsWire (press release), Medicis Reports Second Quarter 2008 Financial Results - Aug 5, 2008 Medicis' acne products include primarily DYNACIN(R), PLEXION(R), SOLODYN(R), TRIAZ(R) and ZIANA(R). Medicis recorded revenues of approximately $40.9 million MarketWatch Medicis Announces Second Quarter 2008 Conference Call and Webcast - Jul 31, 2008 PLEXION(R) (sodium sulfacetamide 10% and sulfur 5%), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), MarketWatch Medicis to Acquire LipoSonix - Jun 16, 2008 LOPROX(R), PLEXION(R), SOLODYN(R), VANOS(R) or TRIAZ(R) products; -- Medicis' ability to effectively compete in the liposuction marketplace; Primenewswire (press release), Medicis Declares Cash Dividend - Jun 11, 2008 SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Primenewswire (press release), Medicis 1Q profit rises on higher acne treatment sales - May 8, 2008 Sales of acne treatments, which include Solodyn, Triaz and Ziana, rose 82 percent to $83.7 million, while non-acne products sales fell 7 percent to $37.8 Forbes, Medicis Reports First Quarter 2008 Financial Results - May 8, 2008 This increase was primarily due to the strength of our acne product category, which includes SOLODYN(R), TRIAZ(R) and ZIANA(R). CNNMoney.com (press release) Medicis Announces First Quarter 2008 Conference Call and Webcast - May 6, 2008 SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) FOXBusiness Ipsen and Medicis Announce Acceptance of Reloxin(R) BLA in ... - May 18, 2008 SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) PR-Inside.com (Pressemitteilung), Medicis Announces the Early Adoption of Online Proxy Materials for ... - Apr 8, 2008 SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Primenewswire (press release), Senetek PLC Announces Riley-Nacht LLC - Leading Global Brand ... - Apr 17, 2008 ...of the Medicis prescription and OTC products, including Lustra(R), Esoterica(R), Dynacin(R), Triaz(R), Novacet(R), Loprox(R), Lidex(R), and Synalar(R). PR Newswire (press release), Medicis Increases Cash Dividend to $0.04 Per Share - 12 Mar 2008 SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Primenewswire (press release), Medicis 4Q Profit Rises on Acne Products - Feb 27, 2008 Sales of acne treatments, which include Solodyn, Triaz and Ziana, rose 22 percent to $79.5 million, while non-acne products sales rose 80 percent to $46.9 Forbes, Medicis 4Q sales up 42% to $140.3M vs TF avg est $130M - Feb 27, 2008 The company attributed robust sales to prescriptions of its core acne products: Solodyn, Triaz and Ziana. Medicis provided first-quarter guidance for CNNMoney.com Medicis Reports Fourth Quarter and Year End 2007 Financial Results - Feb 28, 2008 This increase was primarily due to strength in prescriptions of our core acne products, which include SOLODYN(R), TRIAZ(R) and ZIANA(R). FOXBusiness Thursday's Health Winners & Losers - Feb 28, 2008 MedicisMRX benefitted from strong sales of acne products Solodyn, Triaz and Ziana, posted a fourth-quarter profit of $27.5 million, or 41 cents a share, TheStreet.com Medicis to Present At Merrill Lynch Conference - Feb 5, 2008 SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) FOXBusiness Medicis Reports Third Quarter 2007 Financial Results - Nov 7, 2007 Medicis' acne products include primarily DYNACIN(R), PLEXION(R), SOLODYN(R), TRIAZ(R) and ZIANA(R). Medicis recorded revenue of approximately $44.8 million CNNMoney.com Medicis to Present At 2007 Credit Suisse Annual Healthcare Conference - Nov 12, 2007 SOLODYN(R) (minocycline hcl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) CNNMoney.com Medicis to Present At Leerink Swann Aesthetics Roundtable Conference - Oct 1, 2007 OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide) CNNMoney.com Medicis Has an Earnings Glow - Aug 20, 2007 These products have more than compensated for dwindling sales of its older, off-patent Dynacin, Plexion, and Triaz lines. During the fourth quarter of this BusinessWeek Medicis to Present At Thomas Weisel Partners Healthcare Conference - Sep 4, 2007 OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide) CNNMoney.com Medicis Announces Second Quarter 2007 Conference Call and Webcast - Aug 2, 2007 CNNMoney.comOMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide) Medicis Provides Notice to All Holders of Convertible Notes Due ... - Jun 12, 2007 CNNMoney.comOMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide) Medicis Reports First Quarter 2007 Financial Results - May 8, 2007 Primenewswire (press release),Medicis' acne products include primarily DYNACIN(R), PLEXION(R), SOLODYN(R), TRIAZ(R) and ZIANA(TM). Medicis recorded revenue of approximately $40.6 million Medicis making itself a new home in Scottsdale - Apr 13, 2007 East Valley Tribune,...giants and has established its dominance in dermatological drugs with such market leaders as Dynacin, Triaz, Omnicef, Vanos and new product Solodyn. Medicis to Present At JPMorgan 25th Annual Healthcare Conference - Jan 4, 2007 PharmaLive.com (press release),SOLODYN(TM) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Medicis Declares Cash Dividend - Dec 14, 2006 Primenewswire (press release),...ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(TM) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl ... Medicis Reports Third Quarter 2006 Financial Results Nov 8, 2006 ...for use by the FDA in the US At the end of the September 2006 quarter, the Company's core brands included OMNICEF(R), RESTYLANE(R), SOLODYN(TM), TRIAZ(R) and ... -PrimeZone (press release), Medicis and Dow Pharmaceutical Sciences Announce FDA Approval of ... Nov 8, 2006 ...ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(TM) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl ... -PharmaLive.com (press release), Market Report -- Short Stories (MRX) Oct 19, 2006 ...its Restylane and Reloxin (2008) product offerings, while maintaining a strong presence in the acne category with its Solodyn, Dynacin, Plexion, and Triaz lines ... -MSN Money Medicis to Present at UBS Global Life Sciences Conference Sep 22, 2006 ...ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(TM) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl ... -PrimeZone Medicis Announces Second Quarter 2006 Conference Call and Webcast Jul 31, 2006 ...ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(TM) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl ... -PrimeZone Medicis Reports Second Quarter 2006 Financial Results Aug 2, 2006 At the end of the June 2006 quarter, the Company's core brands included DYNACIN(R), LOPROX(R), OMNICEF(R), PLEXION(R), RESTYLANE(R), SOLODYN(TM), TRIAZ(R) and ... -PrimeZone Medicis Names Jason Hanson Executive Vice President and General ... Jul 12, 2006 ...ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(TM) (minocycline HCl, USP) Extended Release Tablets, TRIAZ(R) (benzoyl ... -PrimeZone Euronext Paris) - Ipsen : Medicis and Ipsen decide to focus ... Jul 12, 2006 OMNICEF® (cefdinir), PLEXION® (sodium sulfacetamide/sulfur), SOLODYN™ (minocycline HCl, USP) Extended Release Tablets, TRIAZ® (benzoyl peroxide), LIDEX ... -Euronext (persbericht) : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |